Alem­bic Gets 4 USFDA Ob­ser­va­tions

The Economic Times - - Companies -

Drug firm Alem­bic Phar­ma­ceu­ti­cals on Mon­day said it has re­ceived four ob­ser­va­tions from the US health reg­u­la­tor af­ter the in­spec­tion of Panelav fa­cil­ity. “The for­mu­la­tions fa­cil­ity of the com­pany at Panelav, Halol was in­spected by the USFDA from March 21 to 25. The com­pany had re­ceived four ob­ser­va­tions which are be­ing ad­dressed by our reg­u­la­tor and qual­ity team,” Alem­bic Phar­ma­ceu­ti­cals said in a fil­ing to BSE. The com­pany, how­ever, did not pro­vide any de­tails about the ob­ser­va­tions it has re­ceived from the United States Food and Drug Ad­min­is­tra­tion (USFDA).


Newspapers in English

Newspapers from India

© PressReader. All rights reserved.